From: Fauci, Anthony (NIH/NIAID) [E]

Sent: Thu, 26 Mar 2020 12:44:24 +0000

Bcc: Crew, Page (NIH/NIAID) [E];Davey, Richard (NIH/NIAID) [E];Dcoepel, Laurie
(NIH/NIAID) (E];Eisinger, Robert (NIH/NIAID) [E];Higgs, Elizabeth (NIH/NIAID) [E];Kuriakose, Safia (NIH)
[C];Lerner, Andrea (NIH/NIAID) [E];Nason, Martha (NIH/NIAID) [E];Seam, Nitin (NIH/CC/CCMD) [E];Singh,
Kanal (NIH/NIAID) [E]# b) (6};Brooks, John T. (CDC/DDID/NCHHSTP/DHPSE);Pau,
Alice (NIH/NIAID) [E];Lane, Cliff (NIH/NIAID) [E]

Subject: Memo to NIH/CDC/VA Support Staff for the HHS Panel on COVID-19 Treatment
Guidelines

 

Dear colleagues,

The purpose of this email is to thank-you for agreeing to provide support to the HHS COVID19
Treatment Guidelines Panel. As you are aware clinicians are doing their best to navigate a
complicated landscape with little to guide them. | realize everyone is very busy and | appreciate
you taking on this additional work at a difficult time.

Anthony S. Fauci, MD

Director

National Institute of Allergy and Infectious Diseases

Building 31, Room 7A-03

31 Center Drive, MSC 2520

National Institutes of Health

Bethesda, MD 20892-2520

Phone:[*(@) 6}

FAX: (301) 496-4409

E-mail:

The information in this e-mail and any of its attachments is confidential and may contain sensitive
information. it should not be used by anyone who is not the original intended recipient. If you
have received this e-mail in error please inform the sender and delete it from your mailbox or any
other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not
accept liability for any statements made that are the sender's own and not expressly made on
behalf of the NIAID by one of its representatives.

  
 

NIH-000222
